Back

Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19

European Heart Journal

23 April 2020
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HYPERTENSION OTHER Pharmacology and Pharmacotherapy

Contributors

Michele M Ciulla
Michele M Ciulla

Author

You may be interested in
thumbnail
Congress Presentation
Are ACE inhibitors still the cornerstone of cardiovascular protection?
27 August 2022
thumbnail
Congress Presentation
Evaluation of cardiorespiratory status of subjects after sars cov 2 infection and the potential role of hypertension as a negative risk factor
21 May 2023
thumbnail
Congress Presentation
Renal and cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: A systematic review and meta-analysis
1 September 2019
thumbnail
Congress Presentation
Effect of switching treatment with Sacubitril/Valsartan from Angiotensin-Inhibitors or Angiotensin Receptor Antagonists in patients with left ventricular systolic dysfunction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources